In these difficult times we extend our thoughts to all those who are directly suffering from the effects of the coronavirus pandemic as well as those who are seeing its far reaching effects on their family and friends. Let us look forward to the future and recovery.

CLAP in 60 Seconds
Bite-sized videos on real-world pharmacotherapy topics
We’re excited to launch a brand new e-learning resource for our members.
ISCP CLAP (CataLysing Real World Pharmacotherapy) is designed to bring to you ready-to-use, bite-sized information about real-world pharmacotherapy topics, at your fingertips. View our latest videos now on our website and on Facebook.

Upcoming Events

11
Feb

26
Mar

2
Apr

15
Apr

15
May
Highlights
The latest reviews, resources and expert analysis from our website.
Webinars and e-Learning: Gender-specific Medicine in Cardiovascular Diseases: Heart Failure in Women
Posted on December 15, 2020
Expert Opinions: Smoking Cessation as a Public Health Measure to Limit the Pandemic of COVID-19
Posted on May 06, 2020
Expert Reviews: Insights for Stratification of Risk in Brugada Syndrome
Posted on January 01, 2021
Clinical Trials: Rivaroxaban in Peripheral Artery Disease after Revascularization
Posted on January 01, 2021
Brief Reports: Summary of Article: ‘Alcohol Abstinence in Drinkers with Atrial Fibrillation’
Posted on July 20, 2020
newsfeed
Addressing non-State actors involvement in WHO’s governing bodies at #EB148
Posted on January 23, 2021
This is a statement made at the 148th session of the WHO Executive Board on Agenda item 22.1 by the World Heart... more
Better parent-physician communication needed for children with heart disease
Posted on January 23, 2021
There are gaps between physicians and parents in knowledge of disease status and prognosis in children with advanced heart disease, according to... more
eGFR variability linked to greater mortality risk but not cardiovascular events
Posted on January 22, 2021
For patients with hypertension, variation in eGFR measurements over time appeared to increase risk for all-cause mortality but did not demonstrate an... more
BMI, physical activity, CVD risk relationship complicated
Posted on January 22, 2021
Increased physical activity may mitigate risk for CVD regardless of BMI, but elevated BMI itself remains a significant CVD risk factor, according... more
ISCP book series
Current Cardiovascular Therapy
Kaski, Juan Carlos.
Series Editor: Juan Carlos Kaski Cardiovascular pharmacotherapy is a fast-moving and complex discipline within cardiology in general. New studies, trials and indications are appearing on a regular basis. This series created with the support of the International Society of Cardiovascular Pharmacotherapy (ISCP) is designed to establish the baseline level of knowledge that a cardiovascular professional needs to know on a day-to-day basis. The information within is designed to allow readers to learn quickly and with certainty the mode of action,...
-
Antiplatelet and Anticoagulation Therapy
A. Ferro, D.A. Garcia (Eds.)
-
Pharmacological Treatment of Acute Coronary Syndromes
Avanzas, Pablo; Clemmensen, Peter(Eds.)
-
Atrial Fibrillation Therapy
Gheorghe-Andrei Dan, Antoni Bayes de Luna, John Camm(Eds.)
board of directors
Providing a leadership and advocacy role amongst members of their national societies.
 
-
Jack Tan
President
Dr Jack Tan graduated from the Faculty of Medicine, National University of Singapore in 1997. In 2007, he spent one year at UC Davis (more…) more
-
Thomas Kahan
Vice President/Co Treasurer
Affiliations/Memberships Professor of Medicine Department of Clinical Sciences, Danderyd Hospital Division of Cardiovascular Medicine (more…) more
-
Pablo Avanzas
Secretary
Affiliations/Memberships Consultant in Invasive Cardiology, Hospital Universitario Central de Asturias, Oviedo, Spain Fellow of (more…) more
-
Doreen Tan
Co Treasurer
Doreen Su-Yin Tan is Associate Professor, Clinical & Pharmacy Practice, at the National University of Singapore. Affiliations (more…) more